pelotontherapeutics.com | Peloton Therapeutics | United States

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
User-agent: * Allow: / # Optimization for Google Ads Bot User-agent: AdsBot-Google-Mobile User-agent: AdsBot-Google Disallow: /_api/* Disallow: /_partials* Disallow: /pro-gallery-webapp/v1/galleries/* # Block PetalBot User-agent: PetalBot Disallow: / Sitemap: https://www.pelotontherapeutics.com/sitemap.xml # Auto generated, go to SEO Tools > Robots.txt Editor to change

Meta Tags

Title	Peloton Therapeutics \| United States \| Cancer,
Description	Peloton Therapeutics is translating groundbreaking scientific insights into first-in-class oral medicines to fight cancer and other serious
Keywords	N/A

Server Information

WebSite	pelotontherapeutics.com
Host IP	23.236.62.147
Location	United States

Related Websites

                        Site
                        Rank
                    

More to Explore

pelotontherapeutics.com Valuation

US$830

Last updated: 2023-05-12 21:13:45

pelotontherapeutics.com has Semrush global rank of 0. pelotontherapeutics.com has an estimated worth of US$ 830, based on its estimated Ads revenue. pelotontherapeutics.com receives approximately 95 unique visitors each day. Its web server is located in United States, with IP address 23.236.62.147. According to SiteAdvisor, pelotontherapeutics.com is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$830
Daily Ads Revenue	US$0
Monthly Ads Revenue	US$23
Yearly Ads Revenue	US$276
Daily Unique Visitors	6
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
pelotontherapeutics.com. 3600	A	pelotontherapeutics.com. 3600	IP: 23.236.62.147
pelotontherapeutics.com. 900	NS	pelotontherapeutics.com. 900	NS Record: ns4.level3.net.
pelotontherapeutics.com. 900	NS	pelotontherapeutics.com. 900	NS Record: cbru.br.ns.els-gms.att.net.
pelotontherapeutics.com. 900	NS	pelotontherapeutics.com. 900	NS Record: cmtu.mt.ns.els-gms.att.net.
pelotontherapeutics.com. 900	NS	pelotontherapeutics.com. 900	NS Record: ns3.level3.net.
pelotontherapeutics.com. 3600	MX	pelotontherapeutics.com. 3600	MX Record: 0 mx2.hc4921-56.iphmx.com.
pelotontherapeutics.com. 3600	MX	pelotontherapeutics.com. 3600	MX Record: 0 mx1.hc4921-56.iphmx.com.
pelotontherapeutics.com. 3600	TXT	pelotontherapeutics.com. 3600	TXT Record: google-site-verification=_L90hrG-SGCrE8SDPrai72r4ZOYUuAPT1riyg96FfnA
pelotontherapeutics.com. 3600	TXT	pelotontherapeutics.com. 3600	TXT Record: MS=ms46641399
pelotontherapeutics.com. 3600	TXT	pelotontherapeutics.com. 3600	TXT Record: ppe-0c96a4f9eaa0c5e23709
pelotontherapeutics.com. 3600	TXT	pelotontherapeutics.com. 3600	TXT Record: v=spf1 include:spf.protection.outlook.com -all
pelotontherapeutics.com. 3600	TXT	pelotontherapeutics.com. 3600	TXT Record: MS=ms81891691
pelotontherapeutics.com. 3600	TXT	pelotontherapeutics.com. 3600	TXT Record: vKt8LsnMu3arRHZ0G4K7BdnM2hLvqY/sN2I5LrdsHtr95Xh8+40bDvhkLHymJaucl+7GnsfN91q2ejoRNexfBQ==
pelotontherapeutics.com. 3600	TXT	pelotontherapeutics.com. 3600	TXT Record: DZC=WHgKQJK
pelotontherapeutics.com. 3600	TXT	pelotontherapeutics.com. 3600	TXT Record: google-site-verification=1pTOTULmb7k1_KkTtbRc3YqGkISTqeiapNKUGEnl_lI
pelotontherapeutics.com. 3600	TXT	pelotontherapeutics.com. 3600	TXT Record: google-site-verification=6fNJnrj1_gVXxdAUKyB1UXPhJVirXKfkH4WvK3fLfi0
pelotontherapeutics.com. 3600	TXT	pelotontherapeutics.com. 3600	TXT Record: google-site-verification=yXv6dy1bC875R_6Im0-AnRID6op1wwh3jJlr6FrZ0do

HtmlToTextCheckTime:2023-05-12 21:13:45

top of page Privacy Policy Translating Novel Scientific Insights Into First-In-Class Medicines Peloton Therapeutics, Inc. is a clinical stage pharmaceutical company focused on translating novel scientific insights into first-in-class medicines for patients with cancer and other debilitating or life-threatening conditions. Peloton is initially targeting HIF-2α, a transcription factor which was previously thought to be intractable using a small molecule. The company is a leader in the field of HIF-2α biology and pioneered the first HIF-2α to enter into clinical development. LEARN MORE Our drug discovery and development efforts focus on identifying novel compounds capable of modulating complex protein-protein interactions that drive disease which have eluded conventional small molecule approaches. © 2020 Peloton Therapeutics, Inc. All rights reserved. Legal | Cookies 2330 Inwood Rd Suite 226, Dallas, TX 75235 +1 (972) 629-4100 580 California St Suite 1658, 16th Floor San Francisco, CA

HTTP Headers

HTTP/1.1 301 Moved Permanently
Date: Mon, 20 Dec 2021 01:04:41 GMT
Content-Length: 0
Connection: keep-alive
location: https://www.pelotontherapeutics.com/
strict-transport-security: max-age=120
Age: 8243
Server-Timing: cache;desc=hit, varnish;desc=hit, dc;desc=96
X-Seen-By: jeslxIFvDH4ulYwNNi+3MiWfEJXUOf1J0Ah0dFlolkk=,sHU62EDOGnH2FBkJkG/Wx8EeXWsWdHrhlvbxtlynkVhxXru1kp4QeOqR5mrLNGS+,m0j2EEknGIVUW/liY8BLLp7Y6RSVJ7K32tAyhVXc0AUXK4CpcIIKXm19QkScmIm+,2d58ifebGbosy5xc+FRalrJNU/9Gkcdtu510/SusrXsQ1SlqRq3D3TPXfZQf6uqRWQ6VSSkcgF2J/w+BFCLosA==,2UNV7KOq4oGjA5+PKsX47ATz+Tfobw8FRwcVo1TZxRtYgeUJqUXtid+86vZww+nL
Cache-Control: no-cache
X-Wix-Request-Id: 1639962281.3831270542257120703
X-Content-Type-Options: nosniff

HTTP/2 200 
date: Mon, 20 Dec 2021 01:04:41 GMT
content-type: text/html; charset=UTF-8
content-length: 338394
link: ; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,
etag: W/"f3f4d89976089dad64f1f65953907929"
content-language: en-US
strict-transport-security: max-age=120
age: 514061
set-cookie: ssr-caching=cache#desc=hit#varnish=hit#dc#desc=42; Max-Age=20; Expires=Tue, 14 Dec 2021 02:17:19 GMT
server-timing: cache;desc=hit, varnish;desc=hit, dc;desc=42
x-seen-by: wmgbEcS9zOENaefw7bU4YTTNfQwROSdUHmsxQxhbaDc=,gv/XVF9HsGpk8A2KWukUzOwfbs+7qUVAqsIx00yI78k=,sHU62EDOGnH2FBkJkG/Wx8EeXWsWdHrhlvbxtlynkVi+P0yj8Af8/paqX0JLrR68,m0j2EEknGIVUW/liY8BLLqz32kGg/0+YmoIOWNy6M58a0sM5c8dDUFHeNaFq0qDu,2d58ifebGbosy5xc+FRaljnLnpBRjsXyhjiwLdkwWgddpLlPgQtrnT3gZqhX8xYyL3hWbPVzoErlts4mCWuYmA==,2UNV7KOq4oGjA5+PKsX47JLK8RyJpywZMHhcnB0ORXZYgeUJqUXtid+86vZww+nL
cache-control: no-cache
vary: Accept-Encoding
accept-ranges: bytes
x-wix-request-id: 1639962281.5848569180671732323
x-content-type-options: nosniff
set-cookie: TS01e85bed=01f0e9313160233c599c7af6b216bccedb4b0b7d70c1ace164f85a1da4b69a7f6c60babd61654a00cd55486417680ec322f0dfaa31; Path=/;SameSite=none;Secure
server: Pepyaka/1.15.10

pelotontherapeutics.com Whois Information

Domain Name: PELOTONTHERAPEUTICS.COM
Registry Domain ID: 1667444199_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.markmonitor.com
Registrar URL: http://www.markmonitor.com
Updated Date: 2019-11-05T21:47:03Z
Creation Date: 2011-07-18T02:06:51Z
Registry Expiry Date: 2025-01-31T11:59:59Z
Registrar: MarkMonitor Inc.
Registrar IANA ID: 292
Registrar Abuse Contact Email: abusecomplaints@markmonitor.com
Registrar Abuse Contact Phone: +1.2083895740
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: CBRU.BR.NS.ELS-GMS.ATT.NET
Name Server: CMTU.MT.NS.ELS-GMS.ATT.NET
Name Server: NS3.LEVEL3.NET
Name Server: NS4.LEVEL3.NET
DNSSEC: unsigned
>>> Last update of whois database: 2021-12-23T08:41:08Z <<<

pelotontherapeutics.com valuation and analysis